Liver transplantation has been successfully performed for almost three decades. Survival rates have improved, partly due to the advent of the immunosuppressant medication cyclosporin. One-year survival rates have increased from 32% a decade ago to 80% and five-year survival rates are now 60-70% 1 . The return to a normal lifestyle after surgery and an increased life expectancy has been accompanied by increases in the numbers of women within this posttransplant population becoming pregnant.
There are increasing numbers of reports in the obstetric literature about the management of these patients, but none describing aspects of anaesthetic management during pregnancy 2, 3 .
CASE REPORT
A 25-year-old G 1 P 0 female presented at 18 weeks' gestation for elective oral gingivectomy. She had previously undergone two orthotopic liver transplants for autoimmune chronic active hepatitis, in 1986 and again in 1988. She had remained well since the second liver transplant.
This patient was on cyclosporin as anti-rejection therapy. It had produced marked oral gingival hyperplasia (a well recognized complication) which bled frequently with talking and eating. The patient required annual surgical gingivectomies for symptom control. The gingivectomies had initially been performed under local anaesthetic in the dental chair, but required seven to eight hours of resection. Subsequent gingivectomies had been performed much more rapidly under general anaesthesia.
The patient presented at 18 weeks' gestation with recurrence of gingival hyperplasia. To defer surgical resection until the end of pregnancy was not an option in view of the potential complications of poor nutrition and anaemia. It was felt the necessity of the surgery outweighed the possible risks involved, so repeat gingivectomy was planned under general anaesthesia in view of the much shorter surgical resection time required, compared with local anaesthesia.
Her current medications were cyclosporin 125 mg po bd, azathioprine 25 mg po daily and famotidine 20 mg po bd.
Physical examination showed an afebrile, slim, 51 kg female. Vital signs were BP 90/60 mmHg, HR80 bpm in regular rhythm and respiratory rate of 14. Examination of the remainder of the cardiovascular and respiratory systems was normal. The abdomen had scars of previous abdominal surgery and uterine fundal height was consistent with gestation of 18 weeks. Marked gingival hyperplasia was noted in an otherwise normal oral cavity. Laboratory tests showed haemoglobin of 93 g/l, mean corpuscular volume (MCV) and mean corpuscular haemoglobin concentration (MCHC) were at the lower limits of normal, platelet count 130 x 10 9 /l, white cell count 4.1 x 10 5 /l, normal coagulation studies (INR and PTT), a slightly raised serum urea of 8.7 mmol/l and a normal creatinine level of 114 mmol/l. Other electrolytes and liver enzymes were within normal limits.
Immunosuppressant medication was continued to the morning of surgery and premedication was her usual dose of famotidine. The patient was placed on the operating table with a right lumbar wedge providing 15° lateral tilt. Monitoring included 3-lead ECG, noninvasive blood pressure, pulse oximeter and capnograph. After pre-oxygenation for three minutes, anaesthesia was induced with thiopentone 175 mg and fentanyl 100 µg, cricoid pressure applied and succinylcholine 100 mg used to facilitate easy oral intubation. Anaesthesia was maintained with 1% isoflurane in 50% nitrous oxide and oxygen. The dental surgeon injected the gingiva with bupivacaine 15 ml 0.25% with adrenaline 1:200,000 before commencing surgical resection. Surgery lasted one hour. The intraoperative course was uneventful. The patient was extubated awake on her left side.
The patient was discharged from hospital 24 hours later without complication. She delivered a live infant, at term, by caesarean section after completing an otherwise uneventful pregnancy.
DISCUSSION
This case illustrates the multiple issues that need to be addressed in the anaesthetic management of a pregnant, post liver transplant patient. These include (1) considerations of the impact of the physiological changes of pregnancy on anaesthesia, (2) risks to the patient and foetus of general anaesthesia during pregnancy, (3) the impact of the physiological adaptations of pregnancy on the transplanted liver, (4) the need to ensure preservation of the transplanted organ function, and (5) the potential problems associated with the immunosuppressants during the perioperative period 4, 5 . Items (1) and (2) are extensively covered in the literature and will not be addressed here.
Pregnancy alters maternal physiology. Under hormonal stimulus there is capillary engorgement of the mucosa throughout the respiratory tract, predisposing to swelling and contact bleeding 6 . Nasal intubation, indicated for dental procedures to maximize surgical access, increases the risk of bacteraemia and infection from the commensal organisms of the nasal flora, which can pose substantial risks to the immunosuppressed patient 7 . Nasal intubation was avoided in this patient in favour of oral intubation.
There are few changes in the liver during pregnancy. Enzyme levels (particularly alkaline phosphate) may rise in up to 35% of individuals during normal pregnancy. These changes make it difficult to detect episodes of transplant rejection in this patient subpopulation and greater reliance is placed on clinical impression and liver biopsies to make this diagnosis. Serum cholinesterase activity is reduced by up to 24% at term, but the duration of action of succinylcholine is not prolonged, because of the larger volume of distribution of the drug.
Isoflurane was the inhalational agent of choice in this patient to maintain anaesthesia. It increases hepatic artery blood flow at both 1 and 2 MAC and is the volatile anaesthetic widely available that relies least on the liver for biotransformation and elimination. There is a decreased oxygen requirement by the liver during anaesthesia, but mean arterial pressure should be maintained at preanaesthetic levels to ensure adequate perfusion and hepatic function 8 . MAC values of volatile agents are reduced during pregnancy, and with local anaesthetic at the operative site, anaesthesia could be maintained in this patient at minimal volatile anaesthetic concentrations.
Common immunosuppressant drug regimens in these patients include azathioprine and cyclosporin. Azathioprine is an antiproliferative drug which may produce megaloblastic anaemia, thrombocytopenia, leucopenia, pancreatitis and hepatoxicity 9 . Azathioprine has been implicated in prolonging the effects of succinylcholine in cats due to inhibition of plasma cholinesterase activity, but there appears to be no effect in humans, and earlier reports of antagonism of nondepolarizing blockade seems not to be clinically significant 10 .
Cyclosporin therapy has complications related to dose and blood levels. The drug is itself hepatotoxic and nephrotoxic. Hepatic toxicity manifests as a rise in the concentration of transaminases in the early weeks of therapy and usually responds to a decrease in dosage. Acute nephrotoxicity manifests with hyperkalaemia and raised serum creatinine due to reduced glomerular filtration and usually responds to reduced dosing 7 . Chronic nephrotoxicity occurs in about 10% of patients. Hypertension is present in 50-70% of patients taking the drug. Aetiology is unclear but increased systemic vascular resistance is present and disappears when the drug is stopped. Calcium channel blocking drugs are the drugs of choice for hypertension in these patients. Similar mechanisms may contribute to the higher incidence of preeclampsia in the pregnant patient taking cyclosporin 2 , 10 to 20% vs 2 to 3% in the general obstetric population 11 . This feature undoubtedly contributes to the higher incidence of delivery by caesarean section (as high as 36%) and small for gestational age infants (up to 60%) 2 .
Cyclosporin may produce neurotoxicity manifesting as tremors, paraesthesias, headaches, confusion, seizures or depression. The mechanism is unclear but may be exacerbated by hypomagnesaemia caused by the drug and perhaps this should be considered in the preoperative biochemical testing, since this may also contribute to prolonged nondepolarizing neuromuscular blockade.
Oral cyclosporin should be taken at least four hours preoperatively to ensure adequate absorption and maintenance of blood levels 12, 13 . All immunosuppressive drugs are available in intravenous form and can be administered by this route if oral medications cannot be taken perioperatively. Of note, parenteral cyclosporin is solubilized in cremophor which has been associated with allergic reactions and should therefore be administered carefully. This case report demonstrates the successful anaesthetic management of pregnant liver transplant recipient undergoing dental surgery. This type of patient will be encountered in increasing numbers by anaesthetists as post-transplant numbers increase.
